High-level production and characterization of a G-protein coupled receptor signaling complex

FEBS Journal

Volumn 276, Issue 16, 2009, Pages 4515-4528

  Marino, Stephen F ^a  

^a MAX PLANCK INSTITUTE FOR BRAIN RESEARCH   (Germany)

Author keywords

G i1; GPCR; GPCR G fusion; Kappa opioid receptor; Semliki Forest Virus

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANOSINE TRIPHOSPHATASE; KAPPA OPIATE RECEPTOR;

ARTICLE; BINDING SITE; ENZYME ACTIVITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION;

ANIMALS; BINDING SITES; CRYSTALLIZATION; GTP-BINDING PROTEIN ALPHA SUBUNITS; GUANINE NUCLEOTIDES; HYDROLYSIS; KINETICS; RATS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, OPIOID, KAPPA; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

MAMMALIA; SEMLIKI FOREST VIRUS;

EID: 68749108522     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07158.x     Document Type: Article

References (57)

1. Fang Y, Lahiri J Picard L (2003) G protein-coupled receptor microarrays for drug discovery. Drug Discov Today 8, 755 761.
2. Milligan G, Feng GJ, Ward RJ, Sartania N, Ramsay D, McLean AJ Carrillo JJ (2004) G protein-coupled receptor fusion proteins in drug discovery. Curr Pharm Des 10, 1989 2001.
3. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE et al. (2000) Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739 745.
4. Li J, Edwards PC, Burghammer M, Villa C Schertler GF (2004) Structure of bovine rhodopsin in a trigonal crystal form. J Mol Biol 343, 1409 1438.
5. Meng EC Bourne HR (2001) Receptor activation: what does the rhodopsin structure tell us? Trends Pharmacol Sci 22, 587 593.
6. Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VR, Sanishvili R, Fischetti RF et al. (2007) Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450, 383 387.
7. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK et al. (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318, 1258 1265.
8. Jaakola VP, Griffith MT, Hanson MA, Cherezov V, Chien EY, Lane JR, Ijzerman AP Stevens RC (2008) The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322, 1211 1217.
9. Warne T, Serrano-Vega MJ, Baker JG, Moukhametzianov R, Edwards PC, Henderson R, Leslie AG, Tate CG Schertler GF (2008) Structure of a beta1-adrenergic G-protein-coupled receptor. Nature 454, 486 491.
10. Minami M Satoh M (1995) Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci Res 23, 121 145.
11. Standifer KM Pasternak GW (1997) G proteins and opioid receptor-mediated signalling. Cell Signal 9, 237 248.
12. Wittert G, Hope P Pyle D (1996) Tissue distribution of opioid receptor gene expression in the rat. Biochem Biophys Res Commun 218, 877 881.
13. Pan ZZ (1998) mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci 19, 94 98.
14. Stanasila L, Pattus F Massotte D (1998) Heterologous expression of G-protein-coupled receptors: human opioid receptors under scrutiny. Biochimie 80, 563 571.
15. Bertin B, Freissmuth M, Jockers R, Strosberg AD Marullo S (1994) Cellular signaling by an agonist-activated receptor/Gs alpha fusion protein. Proc Natl Acad Sci USA 91, 8827 8831.
16. Wurch T Pauwels PJ (2001) Analytical pharmacology of G protein-coupled receptors by stoichiometric expression of the receptor and G(alpha) protein subunits. J Pharmacol Toxicol Methods 45, 3 16.
17. Moon HE, Cavalli A, Bahia DS, Hoffmann M, Massotte D Milligan G (2001) The human delta opioid receptor activates G(i1)alpha more efficiently than G(o1)alpha. J Neurochem 76, 1805 1813.
18. Massotte D, Brillet K, Kieffer B Milligan G (2002) Agonists activate Gi1 alpha or Gi2 alpha fused to the human mu opioid receptor differently. J Neurochem 81, 1372 1382.
19. Pascal G Milligan G (2005) Functional complementation and the analysis of opioid receptor homodimerization. Mol Pharmacol 68, 905 915.
20. Jordan BA Devi LA (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399, 697 700.
21. Xue JC, Chen C, Zhu J, Kunapuli S, DeRiel JK, Yu L Liu-Chen LY (1994) Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor. J Biol Chem 269, 30195 30199.
22. Simonin F, Gaveriaux-Ruff C, Befort K, Matthes H, Lannes B, Micheletti G, Mattei MG, Charron G, Bloch B Kieffer B (1995) kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. Proc Natl Acad Sci USA 92, 7006 7010.
23. Hirst RA, Hirota K, Grandy DK Lambert DG (1997) Coupling of the cloned rat kappa-opioid receptor to adenylyl cyclase is dependent on receptor expression. Neurosci Lett 232, 119 122.
24. Castelli MP, Melis M, Mameli M, Fadda P, Diaz G Gessa GL (1997) Chronic morphine and naltrexone fail to modify mu-opioid receptor mRNA levels in the rat brain. Brain Res Mol Brain Res 45, 149 153.
25. Obermeier H, Wehmeyer A Schulz R (1996) Expression of mu-, delta- and kappa-opioid receptors in baculovirus-infected insect cells. Eur J Pharmacol 318, 161 166.
26. Li J, Chen C, Huang P Liu-Chen LY (2001) Inverse agonist up-regulates the constitutively active D3.49(164)Q mutant of the rat mu-opioid receptor by stabilizing the structure and blocking constitutive internalization and down-regulation. Mol Pharmacol 60, 1064 1075.
27. Torvinen M, Torri C, Tombesi A, Marcellino D, Watson S, Lluis C, Franco R, Fuxe K Agnati LF (2005) Trafficking of adenosine A2A and dopamine D2 receptors. J Mol Neurosci 25, 191 200.
28. Wilson MH Limbird LE (2000) Mechanisms regulating the cell surface residence time of the alpha 2A-adrenergic receptor. Biochemistry 39, 693 700.
29. Ivanovic A (2001) Klonierung rekombinanter Histamin H1-Rezeptoren und deren Charakterisierung, Solubilisierung und Reinigung nach Heterologer Produktion. Johann Wolfgang von Goethe-Universität, Frankfurt am Main.
30. Mack KJ, Lee MF Weyhenmeyer JA (1985) Effects of guanyl nucleotides and ions on kappa opioid binding. Brain Res Bull 14, 301 306.
31. Lawrence DM Bidlack JM (1992) Kappa opioid binding sites on the R1.1 murine lymphoma cell line: sensitivity to cations and guanine nucleotides. J Neuroimmunol 41, 223 230.
32. Seifert R, Wenzel-Seifert K Kobilka BK (1999) GPCR-Galpha fusion proteins: molecular analysis of receptor-G-protein coupling. Trends Pharmacol Sci 20, 383 389.
33. Milligan G (2000) Insights into ligand pharmacology using receptor-G-protein fusion proteins. Trends Pharmacol Sci 21, 24 28.
34. Zelent B, Veklich Y, Murray J, Parkes JH, Gibson S Liebman PA (2001) Rapid irreversible G protein alpha subunit misfolding due to intramolecular kinetic bottleneck that precedes Mg2+ "lock" after GTP/GDP exchange. Biochemistry 40, 9647 9656.
35. Itzhak Y, Hiller JM Simon EJ (1984) Solubilization and characterization of kappa opioid binding sites from guinea pig cerebellum. Neuropeptides 5, 201 204. (Pubitemid 15163363)
36. Porthe G, Frances B, Verrier B, Cros J Meunier JC (1988) The kappa-opioid receptor from human placenta: hydrodynamic characteristics and evidence for its association with a G protein. Life Sci 43, 559 567.
37. Simon EJ, Hiller JM Edelman I (1975) Solubilization of a stereospecific opiate-macromolecular complex from rat brain. Science 190, 389 390.
38. Frances B, Moisand C Meunier JC (1988) Solubilization and characterization of the kappa-opioid receptor type from guinea-pig cerebellum. Eur J Pharmacol 150, 103 111.
39. Ofri D, Ritter AM, Liu YF, Gioannini TL, Hiller JM Simon EJ (1992) Characterization of solubilized opioid receptors: reconstitution and uncoupling of guanine nucleotide-sensitive agonist binding. J Neurochem 58, 628 635.
40. Bouvier M (2001) Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2, 274 286.
41. Gomes I, Filipovska J, Jordan BA Devi LA (2002) Oligomerization of opioid receptors. Methods 27, 358 365.
42. Levac BA, O'Dowd BF George SR (2002) Oligomerization of opioid receptors: generation of novel signaling units. Curr Opin Pharmacol 2, 76 81.
43. Jackson VN, Bahia DS Milligan G (1999) Modulation of relative intrinsic activity of agonists at the alpha-2A adrenoceptor by mutation of residue 351 of G protein gi1alpha. Mol Pharmacol 55, 195 201.
44. Moon HE, Bahia DS, Cavalli A, Hoffmann M Milligan G (2001) Control of the efficiency of agonist-induced information transfer and stability of the ternary complex containing the delta opioid receptor and the alpha subunit of G(i1) by mutation of a receptor/G protein contact interface. Neuropharmacology 41, 321 330.
45. Bahia DS, Wise A, Fanelli F, Lee M, Rees S Milligan G (1998) Hydrophobicity of residue351 of the G protein Gi1 alpha determines the extent of activation by the alpha 2A-adrenoceptor. Biochemistry 37, 11555 11562.
46. Burt AR, Sautel M, Wilson MA, Rees S, Wise A Milligan G (1998) Agonist occupation of an alpha2A-adrenoreceptor-Gi1alpha fusion protein results in activation of both receptor-linked and endogenous Gi proteins. Comparisons of their contributions to GTPase activity and signal transduction and analysis of receptor-G protein activation stoichiometry. J Biol Chem 273, 10367 10375.
47. Koski G Klee WA (1981) Opiates inhibit adenylate cyclase by stimulating GTP hydrolysis. Proc Natl Acad Sci USA 78, 4185 4189.
48. Konig B, Arendt A, McDowell JH, Kahlert M, Hargrave PA Hofmann KP (1989) Three cytoplasmic loops of rhodopsin interact with transducin. Proc Natl Acad Sci USA 86, 6878 6882.
49. Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, Ito S, Ichikawa A Narumiya S (1993) Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 365, 166 170, doi :.
50. Lai FP, Mody SM, Yung LY, Kam JY, Pang CS, Pang SF Wong YH (2002) Molecular determinants for the differential coupling of Galpha(16) to the melatonin MT1, MT2 and Xenopus Mel1c receptors. J Neurochem 80, 736 745.
51. Lundstrom K, Mills A, Buell G, Allet E, Adami N Liljestrom P (1994) High-level expression of the human neurokinin-1 receptor in mammalian cell lines using the Semliki Forest virus expression system. Eur J Biochem 224, 917 921.
52. Berglund P, Sjoberg M, Garoff H, Atkins GJ, Sheahan BJ Liljestrom P (1993) Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Biotechnology (N Y) 11, 916 920.
53. Cassel D Selinger Z (1977) Activation of turkey erythrocyte adenylate cyclase and blocking of the catecholamine-stimulated GTPase by guanosine 5'-(gamma-thio) triphosphate. Biochem Biophys Res Commun 77, 868 873.
54. Ward RJ Milligan G (2004) Analysis of function of receptor-G-protein and receptor-RGS fusion proteins. Methods Mol Biol 259, 225 247.
55. Zhen Z, Bradel-Tretheway BG, Dewhurst S Bidlack JM (2004) Transient overexpression of kappa and mu opioid receptors using recombinant adenovirus vectors. J Neurosci Methods 136, 133 139.
56. Prather PL, McGinn TM, Claude PA, Liu-Chen LY, Loh HH Law PY (1995) Properties of a kappa-opioid receptor expressed in CHO cells: interaction with multiple G-proteins is not specific for any individual G alpha subunit and is similar to that of other opioid receptors. Brain Res Mol Brain Res 29, 336 346.
57. Stanasila L, Lim WK, Neubig RR Pattus F (2000) Coupling efficacy and selectivity of the human mu-opioid receptor expressed as receptor-Galpha fusion proteins in Escherichia coli. J Neurochem 75, 1190 1199.